Immuron (IMRN) Revenue (2016 - 2024)
Immuron (IMRN) recorded quarterly Revenue of -$2612125655.3 billion in Q4 2024, down 110890976120175.95% quarter-over-quarter from $2.4 million in Q4 2023, and down 110890976120175.95% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends
Immuron's Revenue history runs 9 years deep, the most recent figure standing at -$2612125655.3 billion for Q4 2024.
- In Q4 2024, Revenue fell 110890976120175.95% year-over-year to -$2612125655.3 billion; the TTM figure through Dec 2024 stood at -$2612125655.3 billion (down 86383847521610.38% YoY), while the FY2025 annual figure was $4.7 million, up 46.88% from the prior year.
- Revenue was -$2612125655.3 billion for Q4 2024 at Immuron, down from $2.4 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.4 million in Q4 2023 to a low of -$2612125655.3 billion in Q4 2024.
- Historically, Revenue has averaged -$435354275.9 billion across 5 years, with a median of $42316.4 in 2021.
- The sharpest annual moves came in 2021 and 2024: Revenue surged 11389249.91% in 2021, then tumbled 110890976120175.95% in 2024.
- A 5-year view of Revenue shows it stood at $0.01 in 2020, then soared by 11389249.91% to $1690.7 in 2021, then soared by 34421.0% to $583646.0 in 2022, then soared by 303.6% to $2.4 million in 2023, then sank by 110890976120175.95% to -$2612125655.3 billion in 2024.
- The last three Revenue figures came in at -$2612125655.3 billion (Q4 2024), $2.4 million (Q4 2023), and $82942.2 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,612,125,655.29 Bn |
| Dec 31, 2023 | 2.36 Mn |
| Jun 30, 2023 | 82,942.19 |
| Dec 31, 2022 | 583,646.00 |
| Dec 31, 2021 | 1,690.70 |
| Dec 31, 2020 | 0.01 |
| Dec 31, 2019 | 15,566.23 |
| Dec 31, 2018 | 978,233.00 |
| Dec 31, 2017 | 716,323.37 |
| Dec 31, 2016 | 530,121.20 |
| Jun 30, 2016 | 862,831.81 |